Cun Liu

Weifang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinicopathological response and survival outcomes of HER2-low versus HER2-zero early breast Cancer: A systematic review and Meta-analysis.

Clinicopathological response and survival outcomes of HER2-low versus HER2-zero early breast Cancer: A systematic review and Meta-analysis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: April 01, 2026

Therapeutic potential of triple-negative breast cancer immune checkpoint blockers: A 21-year bibliometric analysis.

Therapeutic potential of triple-negative breast cancer immune checkpoint blockers: A 21-year bibliometric analysis.

Journal: Medicine

Published: March 11, 2025

Tubeimoside I inhibits the growth of triple-negative breast cancer via the NR3 C2/PI3 K/AKT signaling pathway.

Tubeimoside I inhibits the growth of triple-negative breast cancer via the NR3 C2/PI3 K/AKT signaling pathway.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 04, 2025

The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer.

The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer.

Journal: Discover oncology

Published: January 28, 2025

Elucidating the Role of Estrogen Effects in Leukemia: Insights from Single-Cell RNA Sequencing and Mendelian Randomization.

Elucidating the Role of Estrogen Effects in Leukemia: Insights from Single-Cell RNA Sequencing and Mendelian Randomization.

Journal: Journal of Cancer

Published: July 07, 2024

Exploring risk factors for autoimmune diseases complicated by non-hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study.

Exploring risk factors for autoimmune diseases complicated by non-hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study.

Journal: Frontiers in immunology

Published: January 23, 2024

T cell senescence: a new perspective on immunotherapy in lung cancer.

T cell senescence: a new perspective on immunotherapy in lung cancer.

Journal: Frontiers in immunology

Published: November 15, 2023

Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.

Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.

Journal: International journal of biological sciences

Published: November 11, 2023

Heterogeneity of primary and metastatic CAFs: From differential treatment outcomes to treatment opportunities (Review).

Heterogeneity of primary and metastatic CAFs: From differential treatment outcomes to treatment opportunities (Review).

Journal: International journal of oncology

Published: November 09, 2023

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target.

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target.

Journal: Frontiers in cell and developmental biology

Published: November 02, 2023

Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.

Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.

Journal: Journal of translational medicine

Published: August 18, 2023

Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells.

Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 06, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026